|Systematic (IUPAC) name|
|Molar mass||375.423 g/mol|
GBLD-345 is an anxiolytic drug used in scientific research, which acts as a non-selective, full-efficacy positive allosteric modulator of the GABAA receptor. It has similar effects to benzodiazepine drugs, but is structurally distinct and so is classed as a nonbenzodiazepine anxiolytic.
- Davies LP, Barlin GB, Ireland SJ, Ngu MM (October 1992). "Substituted imidazo[1,2-b]pyridazines. New compounds with activity at central and peripheral benzodiazepine receptors". Biochemical Pharmacology 44 (8): 1555–61. doi:10.1016/0006-2952(92)90472-U. PMID 1358075.
|This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.|